JH-036

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameJH-036
Drug Alias NameJH-036
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-Delta-like protein 3CD3 T-cell engagers
TargetsDelta-like protein 3T cell surface glycoprotein CD3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBiotech Pharmaceuticals Co LtdAmbotec Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAmbotec Pharmaceutical Co LtdBiotech Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A